LLY

1,128.7

+0.06%↑

JNJ

235.06

-0.36%↓

ABBV

221.75

-0.19%↓

UNH

410.63

-0.37%↓

MRK

115.08

-0.21%↓

LLY

1,128.7

+0.06%↑

JNJ

235.06

-0.36%↓

ABBV

221.75

-0.19%↓

UNH

410.63

-0.37%↓

MRK

115.08

-0.21%↓

LLY

1,128.7

+0.06%↑

JNJ

235.06

-0.36%↓

ABBV

221.75

-0.19%↓

UNH

410.63

-0.37%↓

MRK

115.08

-0.21%↓

LLY

1,128.7

+0.06%↑

JNJ

235.06

-0.36%↓

ABBV

221.75

-0.19%↓

UNH

410.63

-0.37%↓

MRK

115.08

-0.21%↓

LLY

1,128.7

+0.06%↑

JNJ

235.06

-0.36%↓

ABBV

221.75

-0.19%↓

UNH

410.63

-0.37%↓

MRK

115.08

-0.21%↓

Search

10X Genomics Inc (Class A)

Atidarymo kaina

SektoriusSveikatos priežiūra

32.84 4.06

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

31.24

Max

33.47

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2.8M

-13M

Pardavimai

-15M

151M

Pelnas, tenkantis vienai akcijai

0.07

Pelno marža

-8.93

Darbuotojai

1,178

EBITDA

2.5M

-17M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-15.05% downside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.1B

3.9B

Ankstesnė atidarymo kaina

28.78

Ankstesnė uždarymo kaina

32.84

Naujienos nuotaikos

By Acuity

50%

50%

162 / 342 reitingas Healthcare

10X Genomics Inc (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
help-icon Live chat